Compare DCTH & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCTH | NATH |
|---|---|---|
| Founded | 1988 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.5M | 412.2M |
| IPO Year | 2015 | 1996 |
| Metric | DCTH | NATH |
|---|---|---|
| Price | $11.11 | $100.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 378.1K | 17.3K |
| Earning Date | 05-07-2026 | 06-09-2026 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | ★ 107.53 | 22.29 |
| EPS | N/A | ★ 4.17 |
| Revenue | N/A | ★ $104,201,000.00 |
| Revenue This Year | $24.54 | N/A |
| Revenue Next Year | $33.15 | N/A |
| P/E Ratio | ★ N/A | $24.21 |
| Revenue Growth | N/A | ★ 7.81 |
| 52 Week Low | $8.12 | $88.67 |
| 52 Week High | $18.23 | $118.32 |
| Indicator | DCTH | NATH |
|---|---|---|
| Relative Strength Index (RSI) | 53.27 | 50.98 |
| Support Level | $10.17 | $100.01 |
| Resistance Level | $11.24 | $101.89 |
| Average True Range (ATR) | 0.56 | 0.55 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 46.85 | 64.72 |
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.